2013 Financial Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
11/25/13Widespread Acceptance and Use of Accuray's Technologies Continue to Grow
More than 700 CyberKnife® and TomoTherapy® Systems Have Treated More Than Half a Million Patients Worldwide SUNNYVALE, Calif., Nov. 25, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today continued momentum in global adoption of its CyberKnife® and TomoTherapy® Systems. Accuray has expanded its installed base to more than 700 systems worldwide which have been used to treat more than half a million patients, further positioning the company as a leader in precise, innovativ... 
Printer Friendly Version
11/18/13Accuray to Present at Piper Jaffray 25th Annual Healthcare Conference
SUNNYVALE, Calif., Nov. 18, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to present at the Piper Jaffray 25th Annual Healthcare Conference in New York on Wednesday, December 4, 2013 at 1:00 p.m. EST/10:00 a.m. PST. A live webcast of the presentation will be available online from the Investor Relations page of the company's website at http://www.accuray.com/investors. The webcast replay of the presentation will begin approximately... 
Printer Friendly Version
11/07/13Two Papers From a Large Multi-site Study Further Demonstrate Efficacy and Quality of Life Benefits for Prostate Cancer Patients Treated with Accuray's CyberKnife® System
UCLA Researchers Evaluate Long-term Outcomes of More than 1,000 Patients from Multiple Institutions SUNNYVALE, Calif., Nov. 7, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today the publication of two papers stemming from a large multi-center study of CyberKnife® stereotactic body radiotherapy (SBRT) led by investigators at the University of California, Los Angeles (UCLA). The first paper, published in the September 2013 online issue of Radiotherapy & Oncology (comm... 
Printer Friendly Version
11/07/13Accuray Reports Financial Results for First Quarter of Fiscal Year 2014
Gross Orders Increase 17% Year over Year SUNNYVALE, Calif., Nov. 7, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the first fiscal quarter ended September 30, 2013.    Results are presented on a GAAP basis, unless otherwise indicated, as the magnitude of purchase accounting amortization was minimal for fiscal year 2013 and is projected to be minimal for fiscal year 2014 and beyond, making GAAP results comparable on a year over year basis and a ... 
Printer Friendly Version
10/14/13Accuray to Report Financial Results for First Quarter Fiscal 2014
SUNNYVALE, Calif., Oct. 14, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced that it will report results for its first quarter of fiscal 2014, ended September 30, 2013 on Thursday, November 7, 2013 after the market closes. A conference call to review the results will begin at 1:30 p.m. PST/4:30 p.m. EST and will be hosted by Joshua H. Levine, president and chief executive officer and Gregory Lichtwardt, executive vice president and chief financial officer. The confe... 
Printer Friendly Version
10/03/13More than 100 Presentations at Leading Radiation Oncology Meeting Demonstrate High Value and Broad Utilization of Accuray's Treatment Platforms
Data Supports Growing Use of CyberKnife® SBRT for Prostate Cancer SUNNYVALE, Calif., Oct. 3, 2013 /PRNewswire/ -- ASTRO 2013 (Atlanta) – Accuray Incorporated (Nasdaq: ARAY) announced today that studies presented at the 55th Annual American Society for Radiation Oncology (ASTRO) Meeting in Atlanta, September 22 – 25, 2013 continue to reinforce evidence of clinical and quality of life benefits for the CyberKnife® and TomoTherapy® Systems. A variety of indications including prostate, lung, liver... 
Printer Friendly Version
09/22/13Accuray to Showcase Clinical Utilization and Adoption of its Latest Advanced Product Platforms at ASTRO 2013
World's Largest Annual Gathering of the Radiation Oncology Community Provides Multiple Opportunities to Learn about the CyberKnife® M6™ Series and the TomoTherapy® H™ Series Systems SUNNYVALE, Calif. and ATLANTA, Sept. 22, 2013 /PRNewswire/ -- ASTRO 2013 -- Accuray Incorporated (Nasdaq: ARAY) announced today its momentum in gaining adoption for both the new CyberKnife® M6™ Series and TomoTherapy® H™ Series Systems at the 55th Annual American Society for Radiation Oncology (ASTRO) Meeting taki... 
Printer Friendly Version
09/03/13Accuray Incorporated CFO Resigns
Accuray Appoints Successor SUNNYVALE, Calif., Sept. 3, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Derek Bertocci has resigned as Senior Vice President and Chief Financial Officer of the company effective September 2, 2013.  Today, Accuray has appointed Gregory Lichtwardt, executive vice president, chief financial officer, effective immediately.  Mr. Bertocci is anticipated to continue in a consulting role with the Company. Mr. Lichtwardt, age 59, joins A... 
Printer Friendly Version
08/27/13Accuray Announces Results for Fourth Quarter and Fiscal Year 2013
Continued Momentum in New Order Activity and Backlog Provides Guidance for Fiscal 2014 SUNNYVALE, Calif., Aug. 27, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the fourth quarter and fiscal year ended June 30, 2013. Non-GAAP results are provided to enhance understanding of Accuray's ongoing core results of operations. Accuray announced continued strength in new orders booked in the fourth quarter and first patients treated in the United States w... 
Printer Friendly Version
08/26/13Accuray to Host Investor Meeting at ASTRO 2013
SUNNYVALE, Calif., Aug. 26, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced that its management will host an investor meeting on Monday, September 23, 2013 at the annual meeting of the American Society for Radiation Oncology (ASTRO) being held in Atlanta. The meeting is open to institutional investors and research analysts. Accuray Incorporated management will host a breakfast meeting, from 7:00 a.m. to 9:00 a.m. E.D.T. on Monday, September 23 at the OMNI Hotel, 100 C... 
Printer Friendly Version
08/22/13Accuray to Present at Upcoming Investor Conferences
SUNNYVALE, Calif., Aug. 22, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that its management is scheduled to present at two upcoming investor conferences. Accuray Incorporated management is scheduled to present at the 2013 Goldman Sachs European Medtech and Healthcare Services Conference in London on Thursday, September 5, 2013 at 9:45 a.m. GMT/5:45 a.m. EDT. Accuray Incorporated management is also scheduled to present at the 2013 Morgan Stanley Global Healthcar... 
Printer Friendly Version
08/16/13Accuray will showcase its CyberKnife® and TomoTherapy® Systems at CHINA-HOSPEQ 2013
SUNNYVALE, Calif., Aug. 16, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today its participation in the 22nd China International Medical Instruments and Equipment Exhibition and Seminar (CHINA-HOSPEQ), taking place from Friday, August 16 to Sunday, August 18, 2013. For the first time, China's hospital procurement officials will be able to see firsthand Accuray's CyberKnife and TomoTherapy Systems at CHINA-HOSPEQ 2013 (booth #G02). On display in the booth will be system... 
Printer Friendly Version
08/07/13Accuray to Report Financial Results for Fourth Quarter and Year End Fiscal 2013
SUNNYVALE, Calif., Aug. 7, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced that it will report results for its fourth quarter and fiscal year ended June 30, 2013 on Tuesday, August 27, 2013 after the market closes. A conference call to review the results will begin at 2:00 p.m. PDT/5:00 p.m. EDT and will be hosted by Joshua H. Levine, president and chief executive officer and Derek Bertocci, senior vice president and chief financial officer. The conference call dia... 
Printer Friendly Version
06/25/13First U.S. Center Treats Patient with the New TomoHDA™ System
New Tulsa Cancer Institute Offers Accuray's Latest Cancer Fighting Technology SUNNYVALE, Calif., June 25, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that the Tulsa Cancer Institute is the first U.S. center to treat a patient with Accuray's TomoHDA™ System, the latest and most advanced innovation in the TomoTherapy® product lineage designed to treat the full spectrum of cancer patients. Its numerous benefits include streamlined daily 3D CT image guidance for accu... 
Printer Friendly Version
06/13/13First U.S. Center to Treat a Patient with the new CyberKnife® M6™ System
Lancaster General Health Unveils Leading Robotic Radiosurgery System SUNNYVALE, Calif., June 13, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that Lancaster General Health in Pennsylvania is the first U.S. center to treat a patient with the CyberKnife® M6™ System, the most advanced robotic radiosurgery system in the world and the latest generation of the CyberKnife System. The new CyberKnife M6 System was designed to provide clinicians with an enhanced stereotactic... 
Printer Friendly Version
06/05/13First Patient Treated Worldwide with Accuray's New TomoHDA™ System
Advanced Radiation Treatment Now Available to Cancer Patients in France SUNNYVALE, Calif., June 5, 2013 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY), announced today the first patient has been treated with its new TomoHDA™ System at Centre Oscar Lambret in Lille, France. Building upon the proven TomoTherapy® Hi-Art® and TomoHD™ technologies, the TomoHDA System is a fully-integrated radiation therapy system designed to treat the full spectrum of cancer patients. Performance... 
Printer Friendly Version
05/29/13Accuray is Honored for Delivering 'World-Class' Customer Service
Receives Omega's prestigious NorthFace ScoreBoard AwardSM for exceeding customer expectations SUNNYVALE, Calif., May 29, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today it has received the NorthFace ScoreBoard AwardSM from Omega Management Group Corp. in recognition of achieving excellence in customer service and support in 2012. Since 2000, the award has been presented annually to companies who, as rated solely by their own customers, exceeded expectations in custom... 
Printer Friendly Version
05/22/13Accuray Incorporated to Present at 2013 Jefferies Global Healthcare Conference
SUNNYVALE, Calif., May 22, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to present at the 2013 Jefferies Global Healthcare Conference in New York on Thursday, June 6, 2013 at 1:30 p.m. EDT/10:30 a.m. PDT. A live webcast of the presentation will be available online from the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of the presentation will begin approximately one hour... 
Printer Friendly Version
05/21/13New Data Validates CyberKnife SBRT for Prostate Cancer Treatment
Updated ASTRO Model Policy Endorses Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer SUNNYVALE, Calif., May 21, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today the publication of study results involving hundreds of prostate cancer patients treated with the CyberKnife® Robotic Radiosurgery System, the most widely used form of prostate stereotactic body radiation therapy (SBRT). The study followed 304 patients for a median of 5 years, and many to 6 years ... 
Printer Friendly Version
05/07/13Accuray Announces Results for Third Quarter Fiscal 2013
New Order Activity Improves - First Installations of New Models - Guidance Updated SUNNYVALE, Calif., May 7, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced financial results for the third quarter of fiscal 2013 that ended March 31, 2013. Non-GAAP results are provided to enhance understanding of Accuray's ongoing core results of operations. Recent highlights include an upturn in new orders booked in the third quarter, installation of the first new CyberKnife M6 Ser... 
Printer Friendly Version
04/18/13Accuray Provides Clarification on Recently Initiated Voluntary Recalls
SUNNYVALE, Calif., April 18, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today clarification on two voluntary recalls that the company initiated on March 19, 2013. In keeping with its commitment to patient safety and total quality management, Accuray has voluntarily implemented a recall of two separate components from its CyberKnife® product line: the Iris™ Variable Aperture Collimator and the RoboCouch® Patient Positioning System. The affected parts are manufactured by... 
Printer Friendly Version
04/18/13Accuray Incorporated to Report Financial Results for Third Quarter Fiscal 2013
SUNNYVALE, Calif., April 18, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a radiation oncology company, today announced that it will report results for its third quarter of fiscal 2013, ended March 31, 2013 on Tuesday, May 7, 2013 after the market closes. A conference call to review the results will begin at 2:00 p.m. PST/5:00 p.m. EST and will be hosted by Joshua H. Levine, president and chief executive officer and Derek Bertocci, senior vice president and chief financial office... 
Printer Friendly Version
04/04/13First Patient Treated Worldwide with the new TomoEDGE™ Dynamic Jaws Technology
Heidelberg University Hospital pioneers use; providing precise and efficient treatments SUNNYVALE, Calif., April 4, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Heidelberg University Hospital, Germany, has treated the world's first patients with the new TomoEDGE™ Dynamic Jaws technology combined with VoLO™ Planning as part of its TomoTherapy® System. The new TomoEDGE Dynamic jaws technology was introduced at ASTRO 2012 as the newest evolution to the TomoThera... 
Printer Friendly Version
03/28/13Dr. Emad Rizk Joins Accuray Board of Directors
SUNNYVALE, Calif., March 28, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today the appointment of Emad Rizk, M.D. to the company's Board of Directors, effective March 15, 2013. Dr. Rizk is a renowned healthcare industry expert who brings more than 25 years of experience working with payers, hospital systems, government, physicians and pharmaceutical companies to the Accuray board of directors. Since 2003, he has served as president of McKesson Health Solutions, a busin... 
Printer Friendly Version
03/11/13First Center in Hong Kong Treats Patients with CyberKnife® and TomoTherapy® Systems
Hong Kong Adventist Oncology Center Offers Full Spectrum of Disease Treatment with State-of-the-art Technologies SUNNYVALE, Calif., March 11, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Hong Kong Adventist Oncology Center, the first center locally to offer both the CyberKnife® Robotic Radiosurgery and TomoTherapy® Systems, hosted its official opening ceremony last week. Hong Kong Adventist Oncology Center is a newly built cancer center that was designed to a... 
Printer Friendly Version
03/04/13First European Conference on SRS/SBRT and IG-IMRT Held in Milan
SUNNYVALE, California, March 4, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), today announced highlights from the First European Conference on stereotactic radiosurgery/stereotactic body radiation therapy (SRS/SBRT) and image-guided intensity-modulated radiation therapy (IG-IMRT), hosted in partnership with the Istituto Europeo di Oncologia Milano and the Università degli studi di Milano, held in Milan, Italy on February 22-23, 2013. The conference "Radiation Oncology: can ... 
Printer Friendly Version
02/26/13Accuray Incorporated to Speak at Cowen and Company 33rd Annual Healthcare Conference
SUNNYVALE, Calif., Feb. 26, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to present at the Cowen and Company Annual Healthcare Conference in Boston on Tuesday, March  5, 2013 at 9:20 a.m. EST/6:20 a.m. PST.  A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of the presentation will begin approximately o... 
Printer Friendly Version
02/11/13Accuray Incorporated's CEO to Speak at Leerink Swan Global Healthcare Conference
SUNNYVALE, Calif., Feb. 11, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that its president and chief executive officer, Joshua H. Levine, is scheduled to present at the Leerink Swan Global Healthcare Conference in New York on Thursday, February 14, 2013 at 9:20 a.m. EST/6:20 a.m. PST. A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com/investors The ... 
Printer Friendly Version
02/08/13Accuray Prices Offering Of $100 Million Of 3.50% Convertible Senior Notes
SUNNYVALE, Calif., Feb. 8, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) ("Accuray") today announced the pricing of its offering of $100 million aggregate principal amount of 3.50% convertible senior notes due 2018 (the "notes"). The notes are being offered and sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The sale is expected to close on February 13, 2013. Accuray has also granted to the initial purchasers of the notes th... 
Printer Friendly Version
02/06/13Accuray Announces Proposed Offering Of $75 Million Of Convertible Senior Notes
SUNNYVALE, Calif., Feb. 6, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) ("Accuray") today announced its intention to commence an offering, subject to market and other conditions, of $75 million aggregate principal amount of convertible senior notes due 2018 (the "notes"), to be offered and sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Accuray intends to grant the initial purchasers of the notes an option to purchase up ... 
Printer Friendly Version
02/06/13Accuray Announces Results for Second Quarter Fiscal 2013
Decline in Product Revenue Partly Offset by Strong Service Revenue and Profitability SUNNYVALE, Calif., Feb. 6, 2013 /PRNewswire/ -- Accuray Incorporated, a radiation oncology company, (Nasdaq: ARAY) today announced financial results for the second quarter of fiscal 2013 that ended December 31, 2012. Non-GAAP results are provided to enhance understanding of Accuray's ongoing core results of operations. Recent highlights include a continued increase in service revenue and expanding service ... 
Printer Friendly Version
02/04/13First Patient Treated Worldwide with the new CyberKnife® M6™ System
European CyberKnife Center to Offer Patients Advanced Radiosurgery Treatments in Munich SUNNYVALE, Calif., Feb. 4, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a radiation oncology company, announced today that the European CyberKnife Center Munich-Grosshadern (ECZM) has treated the world's first patient with the new CyberKnife® M6™ System. With the installation of the new system, the Munich center, in close cooperation with the University Hospital of Munich, is the first to offe... 
Printer Friendly Version
01/17/13Accuray Incorporated to Report Financial Results for Second Quarter Fiscal 2013
SUNNYVALE, Calif., Jan. 17, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its second quarter of fiscal 2013, ended December 31, 2012 on Wednesday, February 6, 2013 after the market closes. A conference call to review the results will begin at 2:00 p.m. PST/5:00 p.m. EST and will be hosted by Joshua H. Levine, president and chief executive officer and Derek Bertocci, senior vice president a... 
Printer Friendly Version
01/08/13Accuray Incorporated to Speak at Needham's 15th Annual Growth Conference
SUNNYVALE, Calif., Jan. 8, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Needham Growth Conference in New York on Wednesday, January 16, 2013 at 8:00 a.m. EST/5:00 a.m. PST.  A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of the presentatio... 
Printer Friendly Version
01/03/13Accuray Announces Preliminary Results for Second Quarter Fiscal 2013 and Updated Guidance for Fiscal 2013; Announces Restructuring
Conference Call at 5:00 p.m. EST Today SUNNYVALE, Calif., Jan. 3, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today preliminary results for the second quarter of fiscal 2013 that ended December 31, 2012 and updated guidance for fiscal 2013. Non-GAAP results are provided to enhance understanding of Accuray's ongoing core results of operations. The company also is announcing a restructuring of operations. Preliminary consolidated GAAP revenues for second quarter fisca... 
Printer Friendly Version